What's at stake in the Supreme Court mifepristone case
Briefly

On Tuesday, the same justices who undid constitutional protection for abortion will hear arguments in the next frontier of abortion restriction: tightening access across the country for a medication that's used in nearly two-thirds of all abortions nationally.
On one side are anti-abortion rights physicians and organizations... On the other side is FDA and the drugmaker, Danco, who say that the challengers aren't actually harmed by the prescribing rules and that the FDA followed correct procedure and the scientific evidence in making its decisions.
Read at www.npr.org
[
add
]
[
|
|
]